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Abstract
Rationale: Hyperlactatemia in sepsis may derive from a prevalent
impairment of oxygen supply/demand and/or oxygen use.
Discriminating between these two mechanisms may be relevant for
the early fluid resuscitation strategy.
Objectives: To understand the relationship among central venous
oxygen saturation (ScvO2), lactate, and base excess to better
determine the origin of lactate.
Methods: This was a post hoc analysis of baseline variables of 1,741
patients with sepsis enrolled in the multicenter trial ALBIOS (Albumin
ItalianOutcomeSepsis).Variableswere analyzed as a functionof sextiles
of lactate concentrationandsextilesof ScvO2.Wedefined the “alacticbase
excess,” as the sum of lactate and standard base excess.
Measurements and Main Results: Organ dysfunction severity
scores, physiologic variables of hepatic, metabolic, cardiac,
and renal function, and 90-day mortality were measured. ScvO2
was lower than 70% only in 35% of patients. Mortality, organ
dysfunction scores, and lactate were highest in the first and
sixth sextiles of ScvO2. Although lactate level related strongly to
mortality, it was associated with acidemia only when kidney
function was impaired (creatinine .2 mg/dl), as rapidly detected
by a negative alactic base excess. In contrast, positive values of
alactic base excess were associated with a relative reduction of
fluid balance.
Conclusions: Hyperlactatemia is powerfully correlated with
severity of sepsis and, in established sepsis, is causedmore frequently
by impaired tissue oxygen use, rather than by impaired oxygen
transport. Concomitant acidemia was only observed in the presence
of renal dysfunction, as rapidly detected by alactic base excess. The
current strategy of fluid resuscitation could be modified according to
the origin of excess lactate.
Keywords: sepsis; lactic acidosis; venous oxygen saturation; base
excess
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Hyperlactatemia has historically been
associated with adverse outcomes in
critically ill patients (1) and still represents
the strongest outcome indicator in sepsis.
Hyperlactatemia, however, may originate
from a variety of causes, such as a deficit in
oxygen delivery (tissue hypoxia) or
impaired oxygen extraction (2), peripheral
shunting (3), stress (4), and increased
adrenergic stimulation (5). It is not clear,
however, in what proportions these
different events may occur in patients with
sepsis, and how their relative importance
could be clinically discriminated.
Furthermore, hyperlactatemia may
occur in presence or absence of acidemia,
and the reasons for this variability are still
unclear. Finally, but importantly, we
wonder if better recognition of the
mechanism of hyperlactatemia and
acidemia would influence the treatment of
patients with sepsis and positively alter
their outcome.
To address these questions, we
propose a unifying interpretation of the
pathophysiology of lactate in sepsis. This
approach broadens one previously
suggested (6, 7), and still accepted by
many: lactate elevation arises from
tissue hypoxia that originates primarily
from a deficit in oxygen transport. This
common clinical perception often
motivates adherence to the current
resuscitation approach of aggressive
and indiscriminate nonselective
administration of fluid. Our expanded
interpretation is based on accepted
principles that are well known and
documented in isolation but have never
been grouped together and presented as a
unified model. We applied this unifying
conceptual interpretation to a large
dataset of patients with sepsis, derived
from the ALBIOS (Albumin Italian
Outcome Sepsis) study (8), using
the baseline data collected before
randomization. We hypothesized that,
after accounting for potentially relevant
confounders, hyperlactatemia is present
both at high and low values of central
venous oxygen saturation (ScvO2) and that
the presence or absence of kidney injury
determines the final effect of plasma
lactate concentration on pH.
Methods
Patients
This study is a secondary analysis of
the ALBIOS study (8), a multicenter
randomized controlled trial conducted
between 2008 and 2012 in 100 Italian ICUs
that compared the effects of 20% albumin
and crystalloids versus crystalloids alone in
severe sepsis and septic shock. In the
present study, we included 1,741/1,818
patients for whom both serum lactate and
ScvO2 measurements were available at
baseline (see Figure E1 in the online
supplement). Measurements were collected
at baseline (within 24 h from the diagnosis
of sepsis) after randomization and before
the albumin administration. We do not know
the volume or composition of fluids given to
the patients in the emergency room and/or in
ICU before the randomization. Therefore, our
analysis refers to the subsequent phase of
sepsis management.
Study Design
We analyzed baseline clinical, physiologic,
and hemodynamic variables as functions of
lactate concentration, ScvO2 levels, and
alactic base excess (BE) (see below). These
variables were grouped into sextiles that
included similar numbers of patients
(,250 each).
Measured Variables
Clinical. We recorded Sequential Organ
Failure Assessment score (SOFA) (9),
Simplified Acute Physiology Score II (10),
90-day mortality, bilirubin, glucose,
creatinine, albumin, platelet and leukocyte
count, percentage of patients fulfilling the
Sepsis-2 definition (as defined by the
ALBIOS study entry criteria [8]) or
Sepsis-3 criteria (i.e., vasopressor
requirement to maintain mean arterial
pressure> 65 mm Hg with lactate levels
.2 mmol/L) (11, 12), and proportion of
patients requiring renal replacement
therapy (RRT).
Physiologic. Physiologic measurements
included FIO2, arterial and venous partial
pressures of oxygen and carbon dioxide,
arterial and venous pH, arterial BE,
sodium, chloride and potassium, diuresis,
and fluid balance in the first 6 hours after
admission.
Hemodynamic. Hemodynamic
measurements included central venous and
mean arterial pressures, heart rate, use and
dosing of epinephrine, norepinephrine,
ScvO2, arteriovenous difference in oxygen
content, venoarterial difference of CO2
partial pressures, and Hb concentration.
Computed Variables
We computed the standard BE as
standard BE ðmmol=LÞ
¼ HCO ‐3 ðmmol=LÞ2 24:8 mmol=L

1 16:2 mmol=L3 ðpH2 7:4Þ:
We used standard BE rather than actual as
better representative of the buffer base status
of the extracellular fluid (13). See the online
supplement for details.
To better understand the relationship
between hyperlactatemia and acidemia, we
introduce the concept of alactic BE, which
helps in the rapid discrimination between
metabolic acidosis secondary to lactate
accumulation from that caused by an
increase in fixed acids (unmeasured strong
anions):
alactic BE ðmmol=LÞ
¼ standard base excess ðmmol=LÞ
1 lactate ðmmol=LÞ:
This variable focuses on the role of fixed
acids other than lactate in the sepsis
scenario (fixed acids refer to the acids
At a Glance Commentary
Scientific Knowledge on the
Subject: Hyperlactatemia may
originate from different causes and in
patients with sepsis may occur
regardless of tissue oxygenation.
Indeed, hyperlactatemia may occur in
the presence of high or low values of
central venous oxygen saturation. In
addition, hyperlactatemia may occur
with or without acidemia.
What This Study Adds to the
Field: Using a large database of
patients with sepsis, we validated
previous discussions on lactate. Data
suggest that impairment of oxygen use
occurs more frequently than
impairment of oxygen transport.
Acidemia is associated with
hyperlactatemia primarily when renal
function is impaired. A negative alactic
base excess, which estimates negative
strong ions other than lactate,
immediately suggests the presence of
renal dysfunction.
ORIGINAL ARTICLE
Gattinoni, Vasques, Camporota, et al.: Lactatemia in Sepsis 583
[e.g., phosphates and sulfates] that cannot
be eliminated through the lungs).
Statistics
Patient characteristics are reported as
mean6 SD. Lactate and ScvO2 were divided
into sextiles. The division into sextiles was
arbitrarily decided to provide reasonable
resolution power of the model, while
maintaining adequate patient number in
each quantile (z250). In this way, the
results are more easily understandable
than splitting the independent variables
according to restricted cubic splines, which
provide, however, similar results (see online
supplement for details). Comparison of
continuous variables among groups was
made through one-way ANOVA test with
Tukey honest significant difference test for
pair-wise comparisons. Dichotomous
variables were compared using the chi-
square test. A P value less than 0.05 was
considered statistically significant. All
statistical analyses were performed using
R and GraphPad Prism Software.
Study Approval
The protocol of the original ALBIOS study
and the informed-consent process were
approved by the ethics committee at each
participating institution. Written informed
consent or deferred consent was obtained
from each patient.
Results
Lactate and Clinical Variables
As shown in Figure 1, mortality and SOFA
score progressively increased across the
sextiles of lactate. In contrast, the ScvO2
remained remarkably similar (ScvO2 z72%)
throughout the first five sextiles of lactate
(i.e., lactate levels ranging from 0.1 to 5.6
mmol/L) and slightly, but significantly,
decreased to 69.7% in the highest lactate
sextile (i.e., lactate levels from 5.6 to 27
mmol/L). Similarly, pH remained similar
and in the normal range within the first
five sextiles of lactate and decreased
significantly to a mean6 SD of 7.316 0.14
only in the terminal lactate sextile. Most of
the other measured clinical, physiologic,
and hemodynamic variables deteriorated
with increasing lactate levels, as reported in
Table E1. Briefly, central venous pressure
(P= 0.01), heart rate (P, 0.001),
norepinephrine requirements, mean arterial
pressure (P, 0.001), diuresis, and fluid
balance deteriorated progressively
(P, 0.001); PaO2 and PaCO2 values were
similar across all lactate sextiles. There was
no obvious relationship between alactic BE
and lactate level.
ScvO2, Lactate, and Tissue Hypoxia
As shown in Figure 2, the ScvO2, as recorded
in all the patients with sepsis without
exclusions, ranged from 24% to 98%
(median, 73%; interquartile range,
67–79%). As shown in Figure 3, several
clinical variables, including lactate, SOFA
score, and mortality, showed a U-shaped
relationship with the ScvO2. Indeed, the
worst values of these variables were
observed at the lowest and highest levels
of ScvO2. Among the other clinical,
hemodynamic, and laboratory variables
grouped by sextiles of increasing ScvO2 (see
Table E2), creatinine and RRT displayed
U-shaped behavior, central venous oxygen
pressure, PaO2, PaCO2, and central venous
carbon dioxide pressure progressively
increased (P, 0.001); pH (P, 0.003) and
BE (P, 0.001) significantly decreased,
whereas the arteriovenous difference in
oxygen content showed a threefold decrease
(from 6 to 2 ml/dl) from the first to the
sixth ScvO2 sextile (P, 0.001). Conversely,
central venous pressure, heart rate, and
vasoactive drugs requirements were similar
for all sextiles of ScvO2. The average value of
mean arterial pressure remained above
70 mm Hg, showing no clear relationship
with the ScvO2 level.
Lactate, Acidosis, and Alactic BE
According to the physicochemical approach
of Stewart to the acid–base equilibrium (14),
an increase in lactate (a strong negative ion)
leads to a decrease in the strong ion
difference, which finally results in
metabolic acidosis and acidemia. Therefore,
if the pH is not corrected by compensatory
mechanisms, the lactate per se always
produces acidemia. Actually, out of 1,017
patients with lactate greater than 2 mmol/L,
57% had normal pH (.7.35) (Figure 1D;
see Table E1). To better understand this
lack of a consistent correlation between
hyperlactatemia and acidemia, we
introduce the concept of alactic BE. This
variable equals the amount of strong acids,
other than lactate, which are present in the
plasma in abnormal concentrations. The
alactic BE was related to kidney function
(Figure 4), as indicated by its relationship to
creatinine levels, urine output, and use of
RRT. Accordingly, with worsening renal
function, the concentration of fixed acids
other than lactate increased in the plasma.
This dysfunction led to worsening
acidemia, as reflected in more negative
values of alactic BE. Conversely, an alactic
BE near 0 suggested that acidemia was fully
explained by the lactate, because no other
acids were present in excess, whereas a
positive alactic BE suggested either that the
kidney fully compensated for metabolic
acidosis or that additional mechanisms
contributed to metabolic alkalosis (e.g.,
diuretic usage, contraction of the
extracellular volume). Actually, the alactic
BE was strongly associated to the fluid
balance (see Figure E5). In Table E3, we
summarize the most relevant clinical and
physiologic variables as functions of sextiles
of alactic BE.
A Comprehensive Synthesis of the
Results
In Figure 5 we present an integrated view of
our results. As shown, hyperlactatemia was
increased quite independently from V
:
O2/
oxygen delivery (DO2) (see Figure E6A). In
contrast the V
:
O2/DO2, viewed as an
independent variable, strictly determines
the ScvO2 levels: low when the oxygen
transport is low (high V
:
O2/DO2) and high
when oxygen use is impaired (low V
:
O2/DO2).
The physiologically sound ScvO2–V
:
O2/DO2
relationship, unfortunately, is biased by
mathematical coupling, which prevents a
rigorous analysis of possible confounders. In
addition, it is worth emphasizing that ScvO2
might not be representative of the whole-
body average oxygen venous saturation,
even though it is a broadly accepted
surrogate of the mixed venous oxygen
saturation (15). The second independent
variable is renal function, on which we
hypothesize that acidemia should primarily
depend. Among several variables, we found
that PCO2, SOFA without its renal
component, and mean arterial pressure
acted as real confounders both on creatinine
and pH. Including these variables in a
multiple linear regression model, the
creatinine remained the variable most
strongly independently related to the pH (see
online supplement for complete analysis).
Discussion
Over recent decades there has been a
growing evidence that lactate in sepsis and
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shock state may increase for several reasons
other than tissue hypoxia (16). The possible
heterogenous sources of lactate in septic
shock, however, have rarely been
quantified. Alegr´ıa and colleagues (17) in a
retrospective analysis of 90 patients with
septic shock, found that 70 patients
presented elevated lactate in association
with signs of hypoperfusion (including
ScvO2, 70%). In our analysis on 1,741
patients, after admission in ICU, we found
that only 35% of the patients had an ScvO2
less than 70%, whereas 65% had high
lactate coexisting with normal or increased
ScvO2. This finding suggests that high
lactate levels, as observed in an ICU setting
after initial fluid resuscitation made in the
emergency department, are caused by a
macrocirculatory oxygen transport defect
only in a minority of cases. Furthermore,
we found that hyperlactatemia in this
setting is reliably associated with acidemia
only if renal dysfunction is simultaneously
present. Finally, the estimation of the
alactic BE is a useful tool by which the
degree of renal compensation of the acid-
base disorder can be rapidly determined.
Lactate and Tissue Hypoxia
Despite its limitations, ScvO2 is one of the
best surrogates for the assessment of tissue
oxygen availability (i.e., the relationship
between oxygen delivery and demand) and
is widely used in clinical practice. We found
that, on admission, only approximately
35% of our patients had ScvO2 lower than
70%. This finding is consistent with what
has been observed in most large clinical
trials performed for sepsis (18–20).
Although, admittedly, ScvO2 is an imperfect
indicator of the cellular oxygen
environment, it is reasonable to associate
extreme values of ScvO2 either to a
predominant oxygen transport insufficiency
(low ScvO2) or to a predominant oxygen use
impairment (high ScvO2). These two
extremes of ScvO2 are indeed associated
with the highest lactate levels, renal
dysfunction, disease severity, and mortality,
so that ScvO2 has a U-shaped relationship
with these characteristics. This
interpretation is supported by other
findings: the highest arteriovenous oxygen
content difference and the greatest
venoarterial difference in PCO2 were found
in the first ScvO2 sextile (24–62%).
At the opposite extreme, the presence
of hyperlactatemia at the most elevated
ScvO2 levels (78–98%) strongly suggests
mechanisms other than an oxygen
transport deficit. In sepsis, elevated lactate
levels with high ScvO2 may be explained by
a variety of mechanisms ranging from the
lack of pyruvate decarboxylation caused by
thiamine deficiency (21–24) to the
impairment of the electron transport chain
caused by dysfunctional structure of the
respiratory mitochondrial enzymes,
induced, for example, by nitric oxide (25)
or oxygen radicals (26). Another possible
explanation for this association, although
physiologically indistinguishable from the
aforementioned mechanisms, entails the
dysregulation of the microcirculation
leading to peripheral shunting (3, 27).
Lactate and Metabolic Acidosis
An increase in the concentration of lactate
results in metabolic acidosis (i.e., a process
leading to an excess of negative strong ions)
(14, 28). However, acidemia (i.e., an
abnormally high proton concentration [low
pH]) is not necessarily present if other
processes simultaneously promote a
compensatory decrease in negative strong
ions, with consequent widening of strong
ion difference and restoration of pH toward
normality. The kidney has a pivotal role in
correcting for the excess of lactate. Indeed,
given that PaCO2 in our population was
similar across lactate sextiles, the
compensatory mechanisms when present
were mainly caused by an offsetting
increase in the strong ion difference by
the kidney.
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Figure 1. (A–D) The 90-day mortality (A), Sequential Organ Failure Assessment score (B), central
venous oxygen saturation (C), and arterial pH (D) as a function of lactate sextiles at baseline (ICU
admission). Data are presented as mean6SE. Lactate sextile ranges: 1, 0.1–1.2 mmol $ L21; 2,
1.2–1.8 mmol $ L21; 3, 1.8–2.5 mmol $ L21; 4, 2.5–3.5 mmol $ L21; 5, 3.5–5.6 mmol $ L21; and 6,
5.6–27 mmol $ L21. Level of statistical significance: *P, 0.05, **P,0.01, and ***P,0.001. The level
of significance represented in A refers to the chi-square test, whereas for B–D it refers to pairwise
comparison in ANOVA model. Only significant comparisons are displayed. ScvO2 = central venous
oxygen saturation; SOFA=Sequential Organ Failure Assessment score.
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To better understand the relation
between hyperlactatemia and acidemia, we
have introduced the concept of alactic BE,
which helps to quickly discriminate between
metabolic acidosis secondary to lactate from
metabolic acidosis caused, for example, by
an accumulation of fixed acids (unmeasured
strong anions). The role of renal function on
the acid–base balance in sepsis is explicitly
quantified by the alactic BE.
The association of a negative alactic
BE with creatinine .2 mg/dl indicates
that fixed acids other than lactate are
retained in the plasma, meaning that the
kidney is no longer able to compensate
for the lactic acidosis because of an
associated renal dysfunction. An alactic BE
of zero (observed at creatinine z2 mg/dl)
suggests that the kidney is still able to
clear fixed acids but cannot fully
“compensate” for the acidosis induced
by lactate.
A positive alactic BE (generally with a
creatinine ,2 mg/dl) suggests the presence
of metabolic alkalosis, usually caused by
diuretics or volume contraction (29). In
summary, although an abnormally high
lactate per se nearly always indicates
acidosis of some severity, the degree of
associated acidemia depends on renal
ability to compensate. The concept of
alactic BE is a simple, novel, and potentially
useful method to immediately detect and
track these phenomena over time. The
classical BE includes all the information
given by the alactic BE. However, alactic
BE has more practical diagnostic and
therapeutic potential. Indeed, a negative
alactic BE, observed in these patients with
sepsis, alerts the physician to that fact that
the renal function is impaired (unable to
compensate for an excess of negative strong
ions), whereas a positive alactic BE may
indicate an additional process leading to
metabolic alkalosis (e.g., excess use of
diuretics and volume contraction). It
should be noted that the alactic
BE clearly differs from the anion
gap [i.e., (sodium1 potassium)2
(chloride1 bicarbonate)], because this
latter variable does not distinguish
between lactate and other fixed acids. If
the lactate is added to the anion gap
computation, the alactic BE differs
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Figure 2. Observed frequency of distribution of central venous oxygen saturation (ScvO2) at baseline
measured in the whole population at ICU admission. As shown, only a minority of patients presented
an ScvO2 consistent with oxygen transport deficit. Note, however, that the extreme values of ScvO2
(one patient ,25% and three patients .95%) are likely artifactual.
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because it refers to a standard PCO2 and
pH, whereas the anion gap does not. The
weak correlation between alactic BE and
anion gap (adjusted R2 = 0.113) is
reported in Figure E6.
Possible Model of Sepsis
Pathophysiology
We believe that the controversial lactate
shuttle theory (30), broadly applied in
other settings of lactate generation, fits
well with the bulk of our findings. That
construct considers lactate the normal
product of glycolysis (see online
supplement for details and description).
Indeed, the model emphasizes the
importance of lactate as a central key of
glucose metabolism, instead of considering
it, as historically proposed (1), as the result
of anaerobiosis. According to this model,
all molecules of glucose entering the
cytoplasm are metabolized into lactate,
which is finally oxidized to CO2 and water.
If lactate production exceeds oxidative
capacity (e.g., excessive b-adrenergic
stimulation, thiamine deficiency,
respiratory chain impairment, lack of
oxygen), excess lactate is transported out
of the cells, usually in association with a
proton (30). The decrease in pH caused by
the increase in plasma lactate is sensed by
the kidney, which decreases the urinary
strong ion difference (31) to restore the
normal plasma pH.
The plasma concentration of lactate
reaches a plateau if the rate of lactate
production in the nonfunctioning metabolic
units equals the rate of lactate oxidation by
the metabolically active functioning units.
Most organs, primarily the liver, may “clear”
circulating lactate (i.e., completely oxidize
lactate) and the rate of oxidation in the
functioning metabolic units increases
with the lactate input. Indeed, a strong
relationship has been shown between
exogenous lactate input and its oxidation in
patients during dialysis (32), and the same
phenomenon has been observed in
experimental animal models (33).
Therefore, we may hypothesize that in
sepsis, the lactate oxidation capability of the
functioning metabolic units (see Figure
E10) increases with the increased
availability of lactate (34) (see Figures E8
and E11). Interestingly, other metabolites
that normally are oxidized by the Krebs
cycle within the mitochondria (e.g.,
nonesterified fatty acids) behave in sepsis as
does lactate: increased levels promote
higher rates of oxidation (35).
Clinical Implications
Our findings may help account for the
ability of lactate to predict the severity and
outcome of patients with sepsis. Indeed, we
showed that whatever the prevalent
mechanism underlying the deterioration in
organ function in sepsis (i.e., impairment in
the oxygen transport or oxygen use), the end
result is an increase in the production of
lactates and a decrease in their oxidation,
leading to hyperlactatemia. However,
despite this apparent similarity in outcome,
a better understanding of the primary
mechanism of hyperlactatemia, as we
suggest in this model, might guide a more
targeted and less indiscriminate approach
to the management of sepsis. In strictly
following the management guidance
currently advocated, all patients with overt
sepsis would receive similar amount of
fluids, regardless of their mixed venous
oxygen saturation (36).
Actually, a deficit in the oxygen
transport, as suggested by low ScvO2, may
justify a therapeutic approach aiming at
increasing it, such as early goal-directed
therapy (37), and, even better, correcting,
if possible, the precise cause of oxygen
transport impairment. In contrast, at high
ScvO2 (impaired oxygen use) the same
therapeutic approach may seem, at best,
ineffective, as suggested by recent
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See text and online supplement for further
details. ScvO2 = central venous oxygen
saturation; SID= strong ion difference.
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randomized controlled trials (18–20). We
may rationally wonder whether, in such
cases, the mandated use of a fixed amount
of fluid has a sound pathophysiologic
rationale, and whether this approach is
devoid of adverse consequences, as
suggested by studies reporting positive fluid
balance, renal dysfunction, and worse
outcome after aggressive fluid replacement
in sepsis (38, 39).
We suggest that patients might be first
stratified on the basis of ScvO2 to understand
the origin of lactate production, and then
on the basis of the alactic BE to better
understand organ (i.e., kidney) perfusion
and volemia. Changes in this simple
parameter over time may facilitate early
restoration of appropriate fluid balance
and/or prompt the use of RRT.
Conclusions
Our results indicate that in patients with
sepsis: 1) lactate is a powerful marker of
illness severity; 2) abnormal lactate levels,
in established sepsis, seem to be generated
primarily by impaired oxygen transport in
the minority of cases, whereas in the
majority, high lactate more likely results
from impaired tissue oxygen use; and 3) the
degree of acidemia or alkalemia depends
primarily on renal function. The alactic BE
offers a potentially useful way to estimate
renal capability of handling the disturbance
to acid–base equilibrium. A clear
recognition of the mechanisms underlying
lactate elevation should result in an
improved therapeutic approach for the
individual, particularly regarding the
aggressiveness of fluid administration. n
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